PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Annals of Geriatric Medicine and Research10.4235/agmr.20.0082202125133-38Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker TestsHankyung Jun, Sang Kyu Cho, Joanne Yoong, Soeren Mattkehttp://e-agmr.org/upload/pdf/agmr-20-0082.pdf, http://e-agmr.org/journal/view.php?doi=10.4235/agmr.20.0082, http://e-agmr.org/upload/pdf/agmr-20-0082.pdf
Korean Journal of Pediatrics10.3345/kjp.2014.57.3.1102014573110Clinical utilization of cord blood over human health: experience of stem cell transplantation and cell therapy using cord blood in KoreaYoung-Ho Leehttp://kjp.or.kr/upload/pdf/kjped-57-110.pdf
Brain10.1093/brain/awaa46220211442355-356Blood tests to screen for Alzheimer’s diseaseMasud Husainhttp://academic.oup.com/brain/article-pdf/144/2/355/36454520/awaa462.pdf, http://academic.oup.com/brain/article-pdf/144/2/355/36454520/awaa462.pdf
Alzheimer's & Dementia10.1002/alz.046027202016S4Blood‐cell‐based biomarker detection of Alzheimer’s diseaseRichard O Cliffhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.046027, https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.046027
Biomarkers for Preclinical Alzheimer’s Disease10.1007/978-1-4939-7674-4_172018249-258The Ethics of Biomarker-Based Preclinical Diagnosis of Alzheimer’s DiseaseAlexander F. Kurz, Nicola T. Lautenschlagerhttp://link.springer.com/content/pdf/10.1007/978-1-4939-7674-4_17
Biomarker - Indicator of Abnormal Physiological Process10.5772/intechopen.766332018Topological Biomarker of Alzheimer’s DiseaseSanja Josef Golubichttp://www.intechopen.com/download/pdf/61081
Journal of Pharmaceutical and Biomedical Analysis10.1016/j.jpba.2018.03.0162018154227-235A novel silanization agent based single used biosensing system: Detection of C-reactive protein as a potential Alzheimer’s disease blood biomarkerMünteha Nur Sonuç Karaboğa, Mustafa Kemal Sezgintürkhttps://api.elsevier.com/content/article/PII:S0731708517323117?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0731708517323117?httpAccept=text/plain
Evidence-based Healthcare10.1054/ebhc.2000.031620004239Rivastigmine gives marginal improvement for people with Alzheimer’s diseaseJames P. Warnerhttps://api.elsevier.com/content/article/PII:S1462941000903164?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1462941000903164?httpAccept=text/plain
Alzheimer's Research & Therapy10.1186/s13195-022-01001-y2022141Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s diseaseSepehr Golriz Khatami, Yasamin Salimi, Martin Hofmann-Apitius, Neil P. Oxtoby, Colin Birkenbihl, , , https://link.springer.com/content/pdf/10.1186/s13195-022-01001-y.pdf, https://link.springer.com/article/10.1186/s13195-022-01001-y/fulltext.html, https://link.springer.com/content/pdf/10.1186/s13195-022-01001-y.pdf
Alzheimer's Research & Therapy10.1186/s13195-021-00941-12022141Model-based stratification of progression along the Alzheimer disease continuum highlights the centrality of biomarker synergiesMuhammad Usman Sadiq, Kichang Kwak, Eran Dayan, https://link.springer.com/content/pdf/10.1186/s13195-021-00941-1.pdf, https://link.springer.com/article/10.1186/s13195-021-00941-1/fulltext.html, https://link.springer.com/content/pdf/10.1186/s13195-021-00941-1.pdf